Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer

Joseph, Emmanuella; Hyacinthe, Micheline; Lyman, Gary H.; Busch, C Von; Demps, LaTara; Reintgen, Douglas S.; Cox, Charles E.

doi:10.1007/bf02303645

Cited by 63 publications

(25 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding stresses the point that patients need to be educated about the effectiveness of follow-up examinations. It is now generally accepted that routine surveillance for the early detection of breast cancer recurrence at distant sites does not improve survival (GIVIO Investigators, 1994;Rosselli et al, 1994;Joseph et al, 1998;Palli et al, 1999). The fact that patients expected to have more chance of survival by performing more tests and detect metastases at an early stage means that they lack information on the primary goals of followup.…”

Section: Discussionmentioning

confidence: 99%

Patient's needs and preferences in routine follow-up after treatment for breast cancer

et al. 2004

View full text Add to dashboard Cite

The purpose of the study was to analyse the needs of women who participated in a routine follow-up programme after treatment for primary breast cancer. A cross-sectional survey was conducted using a postal questionnaire among women without any sign of relapse during the routine follow-up period. The questionnaire was sent 2 -4 years after primary surgical treatment. Most important to patients was information on long-term effects of treatment and prognosis, discussion of prevention of breast cancer and hereditary factors and changes in the untreated breast. Patients preferred additional investigations (such as X-ray and blood tests) to be part of routine follow-up visits. Less satisfaction with interpersonal aspects and higher scores on the Hospital Anxiety and Depression Scale (HADS) scale were related to stronger preferences for additional investigation. Receiving adjuvant hormonal or radiotherapy was related to a preference for a more intensive follow-up schedule. There were no significant differences between patients treated with mastectomy compared to treated with breast-conserving therapy. During routine follow-up after a diagnosis of breast cancer, not all patients needed all types of information. When introducing alternative follow-up schedules, individual patients' information needs and preferences should be identified early and incorporated into the follow-up routine care, to target resources and maximise the likelihood that positive patient outcomes will result.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient's needs and preferences in routine follow-up after treatment for breast cancer

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Previous studies have reported that 50%-72% of ipsilateral recurrences [14][15][16][17] and 37%-80% of contralateral new primaries [17][18][19][20][21] are mammographically-detected. Two studies also reported that the sensitivity of surveillance mammography was lower in young women with a past history of breast cancer than in their older counterparts.…”

Section: Discussionmentioning

confidence: 98%

Outcomes of Surveillance for Contralateral Breast Cancer in Patients Less than Age 60 at the Time of Initial Diagnosis

et al. 2012

View full text Add to dashboard Cite

Background: After an initial diagnosis of breast cancer, the risk of contralateral breast cancer is approximately 0.5% per year. Annual mammography is recommended to identify local recurrences and contralateral new primaries. Because the sensitivity of mammography tends to be lower in younger women, we conducted a retrospective review of the method of detection and pathologic stage of metachronous contralateral primary breast cancers according to age at diagnosis in a cohort of breast cancer patients. Methods: The Henrietta Banting Database contains information on cases of breast cancer diagnosed at Women’s College Hospital from 1987 to 2004. From among 1992 women in the database, 71 patients were identified who were initially diagnosed before age 60 and who subsequently developed a contralateral breast cancer. Medical records were obtained for 53 of the 71 patients. Results: Of the 53 contralateral cancers, 33 (62%) were detected by mammography, including 4 in 16 patients (25%) diagnosed before age 50 and 29 in 37 patients (78%) diagnosed at age 50 or older (p ≤ 0.001). Conclusions: Mammography has poor sensitivity for the surveillance of contralateral breast cancer in early-onset breast cancer patients. Other imaging modalities should be evaluated in this setting.

show abstract

“…[31][32][33] 31,32 It is presumed, therefore, that mammography, combined with clinical examination, allows the earliest possible diagnosis of IBTR and also allows surveillance of the contralateral breast for the detection of MCBC. Whether such surveillance regimens reduce mortality remains unclear at present.…”

Section: Description Of Technologymentioning

confidence: 99%

“…However, only one study reported outcome and this showed there was no difference in survival when comparing mammographic detection of the tumour with other methods. 33 The authors did not conduct a meta-analysis and concluded that further research is needed to better define the optimum surveillance mammography regimen following breast cancer treatment.…”

Section: Grunfeld and Colleaguesmentioning

confidence: 99%

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation

2012

Clinical Governance: An International Journal

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTAThe clinical effectiveness and costeffectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indir...

show abstract

Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer

Abstract: There is no survival benefit to routine intensive follow-up regimens in detecting recurrent breast cancer. Expensive diagnostic tests such as bone scans, CT scans, and serial tumor markers are best used for detection of metastasis in symptomatic patients.

Cited by 63 publications

References 25 publications

Patient's needs and preferences in routine follow-up after treatment for breast cancer

Patient's needs and preferences in routine follow-up after treatment for breast cancer

Outcomes of Surveillance for Contralateral Breast Cancer in Patients Less than Age 60 at the Time of Initial Diagnosis

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation

Contact Info

Product

Resources

About